The Third Five Years
In this issue, as part of our 20th anniversary celebration, we are pleased to honor the third editorial team that was responsible for Hypertension from 1989–1993. This month we recognize Drs Allyn L. Mark and Gerald F. DiBona, who served as Editors-in-Chief from 1989 to 1992 and 1992 to 1993, respectively, while they shared editorial responsibilities at the University of Iowa College of Medicine in Iowa City. They were ably supported by Drs Francois M. Abboud, Donald D. Heistad, and Larry S. Tobacman during this five-year period. Dr DiBona also supported Dr Mark during Dr Mark’s term. It was during their tenure that the journal became established as a major scientific journal even though it met with increasing competition from no fewer than seven other hypertension journals. Despite this auspicious competition, Hypertension endured, and we are grateful to this team from Iowa for maintaining the journal’s position and esteem as viewed by investigators the world over.
Once again, we have identified the top 25 manuscripts according to their frequency of citation in the world scientific literature. However, 26 references are included since the 25th and 26th papers were tied in the number of citations. We again emphasize that these papers are listed alphabetically according to the last name of the first author. These papers are as follows:
Anderson EA, Mark AL. The vasodilator action of insulin: implications for the insulin hypothesis of hypertension. Hypertension. 1993;21:136–141.
Baron AD, Brechtel-Hook G, Johnson A, Hardin D. Skeletal muscle blood flow: a possible link between insulin resistance and blood pressure. Hypertension. 1993;21:129–135.
Berk BC, Vekshtein V, Gordon HM, Tsuda T. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension. 1989; 13:305–314.
Buga GM, Gold ME, Fukuto JM, Ignarro LG. Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension. 1991; 17:187–193.
Bumpus FM, Catt KJ, Chiu AT, DeGasparo M, Goodfriend T, Husain A, Peach MJ, Taylor DG Jr, Timmermans PB. Nomenclature for angiotensin receptors: a report of the Nomenclature Committee of the Council for High Blood Pressure Research. Hypertension. 1991;17:720–721.
Chobanian AV, Haudenschild CC, Nickerson C, Drago R. Antiatherogenic effects of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension. 1990;15:327–331.
Clozel M, Kuhn H, Hefti F. Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension. 1990;16:532–540.
Dzau VJ, Gibbons GH, Pratt RE. Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia. Hypertension. 1991;18(suppl 4)II-100–II-105.
Erdos EG. Angiotensin I converting enzyme and the changes in our concepts through the years: Lewis K. Dahl Memorial Lecture. Hypertension. 1990; 16:363–370.
Gardiner SM, Compton AM, Bennett T, Palmer RM, Moncada S. Control of regional blood flow by endothelium-derived nitric oxide. Hypertension. 1990; 15:486–492.
Griffin SA, Brown WC, MacPherson F, McGrath JC, Wilson VG, Korsgaard N, Mulvany MJ, Lever AF. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension. 1991; 17:626–635.
Harrap SB, Van der Merwe WM, Griffin SA, Macpherson F, Lever AF. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension. 1990;16:603–614.
Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension: Dual processes of remodeling and growth. Hypertension. 1993;21:391–397.
Ignarro LJ. Nitric Oxide: A novel signal transduction mechanism for transcellular communication. Hypertension. 1990;16:477–483.
Janiak P, Pillon A, Prost JF, Vilaine JP. Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension. 1992; 20:737–745.
Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, Schwartz SM. Renal injury from angiotensin II-mediated hypertension. Hypertension. 1992;20:298–303.
Kato T, Iwama Y, Okumura K, Hashimoto H, Ito T, Satake T. Prostaglandin H2 may be the endothelium-derived contracting factor released by acetylcholine in the aorta of the rat. Hypertension. 1990; 15:475–481.
Luscher TF, Boulanger CM, Dohi Y, Yang ZH. Endothelium-derived contracting factors. Hypertension. 1992;19:117–130.
O’Rourke M. Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension. Hypertension. 1990;15:339–347.
Parati G, Casadei R, Groppelli A, Di Rienzo M, Mancia G. Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing. Hypertension. 1989;13(pt 1):647–655.
Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthesis: A new model of arterial hypertension. Hypertension. 1992;20:298–303.
Schichiri M, Hirata Y, Ando K, Emori T, Ohta K, Kimoto S, Ogura M, Inoue A, Marumo F. Plasma endothelin levels in hypertension and chronic renal failure. Hypertension. 1990;15:493–496.
Vanhoutte PM. Endothelium and control of vascular function. State of the Art Lecture. Hypertension. 1989;13(pt 2):658–667.
Wiemer G, Schölkens BA, Becker RH, Busse R. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension. 1991;18:558–563.
Wong PC, Price WA Jr, Chiu AT, Carini DJ, Duncia JV, Johnson AL, Wexler RR, Timmermans PB. Nonpeptide angiotensin II receptor antagonists: Studies with EXP9270 and DuP 753. Hypertension. 1990;15(pt 2):823–834.
Wong PC, Price WA Jr, Chiu AT, Duncia JV, Carini DJ, Wexler RR, Johnson AL, Timmermans PB. Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats: Nonpeptide angiotensin II receptor antagonists; X. Hypertension. 1990;15:459–468.